NCT00334178View on ClinicalTrials.gov

Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine

PHASE3CompletedINTERVENTIONAL
Enrollment

74

Participants

Timeline

Start Date

November 30, 2004

Study Completion Date

September 30, 2006

Conditions
Migraine With AuraMigraine Without Aura
Interventions
DRUG

Laxymig ER (drug)

Trial Locations (7)

112

Taipei Veterans General Hospital, Taipei

Unknown

Changhua Christian Hospital, Changhua

Chung-Ho Memorial Hospital, Kaohsiung Medical University, Kaohsiung City

Chang-Gung Memorial Hospital, Linkou District

Chinese Medical University Hospital, Taichung

SinLau Christian Hospital, Tainan City

Taipei Medical University Hospital, Taipei

Sponsors
All Listed Sponsors
lead

Lotus Pharmaceutical

INDUSTRY

NCT00334178 - Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine | Biotech Hunter | Biotech Hunter